← Leaderboards
Erik Russell Nelson
Duke University
$3,194,432
Attributed
$3,764,985
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $570.6K · FY2013–25$1M$750K$500K$250K$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,764,985 · 4
By mechanism
R01$2,848,647 · 2
R00$726,680 · 1
K99$189,658 · 1
Top collaborators
- Andrew Michael Smith2 shared
Most similar at Duke University
Same institution · by research overlap
- Donald P McDonnell$25,108,849
- Hui-Kuan Lin$13,610,941
- Goldis Malek$10,013,248
- Adrienne D Stiff-Roberts$2,106,877
- Vidyalakshmi Chandramohan$2,415,378
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsCessation Of LifeNeoplasm MetastasisMouse ModelAgonistMalignant Breast NeoplasmBreast Cancer ModelDistalHypercholesterolemiaMediatingLife StyleHydroxymethylglutaryl-Coa Reductase InhibitorsFoundationsDietLink27-HydroxycholesterolInvestigationCancer EtiologyCholesterolIncidenceEstrogen ReceptorsBreast Cancer Risk FactorPreventRecurrence
Grant awards (12)
Translational Combinations of Nanocarriers and Blockers for Metastatic Breast Cancer$570,553
R01 · FY2025 · CA
Translational Combinations of Nanocarriers and Blockers for Metastatic Breast Cancer$570,553
R01 · FY2024 · CA
Impact of cholesterol and its metabolites on breast cancer progression$332,586
R01 · FY2023 · CA · contact PI
Impact of cholesterol and its metabolites on breast cancer progression$339,375
R01 · FY2022 · CA · contact PI
Impact of cholesterol and its metabolites on breast cancer progression$339,375
R01 · FY2021 · CA · contact PI
Impact of cholesterol and its metabolites on breast cancer progression$343,181
R01 · FY2020 · CA · contact PI
Impact of cholesterol and its metabolites on breast cancer progression$353,024
R01 · FY2019 · CA · contact PI
27-hydroxycholesterol as a link between obesity and breast cancer pathogenesis$240,780
R00 · FY2016 · CA · contact PI
27-hydroxycholesterol as a link between obesity and breast cancer pathogenesis$244,752
R00 · FY2015 · CA · contact PI
27-hydroxycholesterol as a link between obesity and breast cancer pathogenesis$241,148
R00 · FY2014 · CA · contact PI
27-hydroxycholesterol as a link between obesity and breast cancer pathogenesis$94,829
K99 · FY2014 · CA · contact PI
27-hydroxycholesterol as a link between obesity and breast cancer pathogenesis$94,829
K99 · FY2013 · CA · contact PI